COSCIENS Biopharma Inc. (CSCIF)
OTCMKTS · Delayed Price · Currency is USD
2.150
-0.010 (-0.46%)
At close: Jan 15, 2026
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of $6.75 million as of January 20, 2026. Its market cap has increased by 26.97% in one year.
Market Cap
6.75M
Enterprise Value
367.88K
Revenue
9.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.15
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 10.88B to 6.75M, a decrease of -99.94%. That is a compound annual growth rate of -21.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 6.75M | 2.40% |
| Dec 31, 2025 | 6.59M | 37.08% |
| Dec 31, 2024 | 4.81M | -49.10% |
| Dec 29, 2023 | 9.45M | -38.75% |
| Dec 30, 2022 | 15.43M | -64.65% |
| Dec 31, 2021 | 43.65M | 64.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |